When administering Heparin, key nursing considerations include monitoring patient status, checking critical laboratory values, and providing appropriate safety education. Unsafe practices such as stopping medications abruptly or doubling missed doses are incorrect.
In-depth explanation
Clinical reasoning summary
Post-operative resumption of bridge anticoagulation
Resumption timing balances the risk of bleeding from the surgical site against the risk of thromboembolic events (stroke, DVT/PE). Standard approach (per CHEST and ACC guidelines):
• Hemostasis confirmed by surgical team is the first prerequisite.
• Low bleeding risk procedures: resume therapeutic LMWH ~24 hours post-op.
• High bleeding risk procedures (major abdominal, neuraxial, intracranial, vascular): wait 48-72 hours; consider prophylactic-dose LMWH first, then advance to therapeutic dose.
• Warfarin restart: typically the day of surgery or the next day (because warfarin takes 5-7 days to achieve therapeutic INR).
• Overlap LMWH and warfarin until INR is therapeutic (≥2.0) for 24-48 hours, then discontinue LMWH.
• Continue prophylactic VTE measures (mechanical compression, ambulation, hydration) until therapeutic anticoagulation resumes.
• Adjust based on individual bleeding/clotting risk; monitor for hematoma, bleeding, thrombosis.
Option 1 (1 hour) is too soon for therapeutic anticoagulation. Option 3 (7 days) is too long and increases thromboembolic risk. Option 4 (warfarin only) ignores the protective bridge needed during warfarin warm-up.
For study reference only. Always follow current clinical guidelines and your institution’s protocols.